HEB 2.3
Hemispherx Biopharma, Inc., a biopharmaceutical company, engages in the clinical development and manufacture of drugs for the treatment of viral and immune-based chronic disorders. Its products include Ampligen, an experimental drug currently undergoing clinical development for the treatment of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and HIV; and Alferon N Injection, a preclinical development product for the treatment of Multiple Sclerosis and West Nile Virus, as well as for the treatment of genital warts, hepatitis C, HIV, and severe acute respiratory syndrome. In addition, the company's Alferon LDO is an experimental low-dose, oral liquid formulation of natural alpha interferon, which is used for the treatment of viral diseases.
 |
